David M. Kraemer work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
David M. Kraemer personal email
- Valid
David M. Kraemer phone numbers
Driving go-to-market strategy, capital raising, deal sourcing, due diligence, investments, partnerships, negotiations, licensing, and alliances for high-growth companies and venture capital funds focused on transformational products and solutions. Primary sectors include Life Sciences, Biotech, MedTech, Devices, Robotics, Automation, and Nanotech. Also highly effective at cross-functional team collaboration, negotiating agreements, communications, analysis, and influencing internal and external stakeholders, investment committees, boards, legal, syndicates, and tax advisors. My SMART Capital™ investor base includes single-family offices, venture capital funds, endowments, foundations, corporations, sovereign wealth funds, and outsourced chief investment officer firms within North America, Europe, and the APAC region.
-
Founder And PublisherTech2BiotechPittsburgh, Pa, Us
-
Founder And Managing Member10 || 2 Capital Partners, LlcPittsburgh, Pa, Us -
Senior Investment ExecutiveCetera Investment Services Llc Dec 2023 - PresentSt. Cloud, Mn, UsInvestment Strategies · Strategic Asset Allocation · Manager Selection · Governance · Planning · Fiduciary · Strategic Partnerships · Business Development · Cross-team Collaboration · Alternative Investments -
Founder & Managing Member10 || 2 Capital Partners, Llc Jan 2016 - PresentPittsburgh, Pennsylvania, Us10 || 2 Capital Partners, LLC selectively advises high-growth companies and venture capital funds.Primary sectors include:* Life Sciences, * Digital Health, * Medical Devices, * Robotics and Automation,* AI Key Strengths:* Go-to-market strategy, * Capital raising, * Deal sourcing, * Due diligence, * Investments, * Partnerships,* Marketing and Investor Presentations Also highly effective at:* Cross-functional team collaboration, * Negotiating agreements, * IR and communications, analysis,* Influencing internal and external stakeholders, investment committees, boards, legal, and tax advisors. My SMART Capital™ investor base includes:* Single-family offices, * Venture capital funds, * Endowments and Foundations, * Corporations, * Sovereign wealth funds, * Outsourced chief investment officer (OCIO) firms within North America, Europe, and the APAC region. -
Biotech Fellow - Summer 2024No Patient Left Behind Jun 2024 - Aug 2024Washington, District Of Columbia, UsAs a Biotech Fellow at No Patient Left Behind, founded by RA Capital's Peter Kolchinsky, I am collaborating with industry leaders and experts to address critical challenges in biotechnology, striving to make a meaningful impact on patient care, health policy, and healthcare innovation. #Biotech #HealthcareInnovation #PatientAdvocacy #LifeSciences #HealthcarePolicy#Pharmaceuticals #ClinicalResearch #DrugDevelopment #OutOfPocketCosts #PriceControls -
Wealth Management & Non-Profit Institutional InvestmentTiaa Sep 2012 - Nov 2015New York, Ny, UsResults-driven, Senior Advisor holding FINRA Series 7 and 66 licenses guiding individuals and families with balance sheet levels requiring bespoke investment management, planning, and charitable / legacy solutions. Additionally, I focused on sourcing and partnering with foundation, endowment and other long-term institutional investors seeking global multi-asset portfolios, including outsourced chief investment officer (OCIO) services. -
Vice President Of Institutional Sales And Business DevelopmentWilshire Associates Sep 2005 - Jul 2011Santa Monica, Ca, UsEntrepreneurial, investment professional responsible for sourcing, developing, and closing institutional investment consulting clients nationwide comprised of private and public pension plans, endowments, foundations, insurance companies, and OPEB trusts. ✥ Self-generated over $60 billion in plan sponsor assets yielding over $3 million in annual retainer fees.✥ Self-generated over $1 million in one-time project fees.✥ Sourced and closed first and largest risk management investment consulting client within division (2007).✥ Increased division client base each year.✥ Accelerated interest in the Wilshire Compass investment technology product by over 200%.Speaking Engagements: Investment Management Institute (IMI), Greenwich, CT.• IMI 27th Consultants Congress, “Building Value at the First Meeting”, San Francisco, CA, 2011• IMI 25TH Consultants Congress, “Winning the Finals”, New York, NY, 2010• IMI Endowment & Foundations Forum, “Distressed vs. Stressed Debt”, Longboat Key, FL, 2009• IMI 22nd Consultants Congress, “Marketing and Servicing the 401(k) Marketplace”, San Francisco, CA, 2008• IMI Faith-Based Investment Leadership Forum, “Hedge Funds”, Longboat Key, FL, 2007 -
Vice PresidentMerrill Lynch Oct 1996 - Sep 2005New York, Ny, UsSenior Financial Advisor with business development and investment advisory experience in private wealth management, corporate retirement plans, commercial lending, capital markets, and the origination of private equity and subordinated debt transactions. 717 Fifth Avenue, New York, NY 10022✥ Self-generated $290 million in private wealth investment assets, corporate loans and private sector retirement plans.✥ Increased assets under management by more than 15% each year.✥ Broad consultative sales experience in acquiring, servicing and implementing customized investment and credit solutions for affluent families, corporations and senior executives of public and private companies.✥ Professional Development Program mentor.✥ Selected to present "consultative sales mindset" and getting to the “C” level accounts to financial advisor trainees.✥ Proven relationship building and negotiating skills with executives of public and private companies to uncover proprietary transaction opportunities✥ Reciprocal business relationships among accountants, attorneys, and other spheres of influence.✥ Origination of private transactions requiring growth capital, emergence financing, mezzanine capital, secondary offerings, senior debt and real estate financing.
David M. Kraemer Skills
David M. Kraemer Education Details
-
The Johns Hopkins UniversityConcentration In Legal And Regulatory Affairs. -
Indiana University Of PennsylvaniaEnglish / Pre-Law And Economics -
Erasmus University RotterdamAnd Venture Capital -
University Of GenevaPrecision Medicine -
The Johns Hopkins UniversityDigital Health Entrepreneurship -
Corporate Finance Institute® (Cfi)Esg Fundamentals -
Mt. Lebanon High School
Frequently Asked Questions about David M. Kraemer
What company does David M. Kraemer work for?
David M. Kraemer works for Tech2biotech
What is David M. Kraemer's role at the current company?
David M. Kraemer's current role is Founder and Publisher.
What is David M. Kraemer's email address?
David M. Kraemer's email address is dk****@****ail.com
What is David M. Kraemer's direct phone number?
David M. Kraemer's direct phone number is +160854*****
What schools did David M. Kraemer attend?
David M. Kraemer attended The Johns Hopkins University, Indiana University Of Pennsylvania, Erasmus University Rotterdam, University Of Geneva, The Johns Hopkins University, Corporate Finance Institute® (Cfi), Mt. Lebanon High School.
What are some of David M. Kraemer's interests?
David M. Kraemer has interest in Leadership, Technology, Health, Private Wealth Management, Abstract Art, Environment, Fitness, Family, Trail, Mountain Running.
What skills is David M. Kraemer known for?
David M. Kraemer has skills like Investments, Entrepreneurship, Leadership, Alternative Investments, Management, Executive Management, Asset Management, Wealth Management, Investment Advisory, Hedge Funds, Asset Allocation, Business Development.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial